Background
Whether human T-lymphotropic virus type 1 (HTLV-1) carriers can develop sufficient humoral immunity after coronavirus disease 2019 (COVID-19) vaccination is unknown.Methods
To investigate humoral immunity after COVID-19 vaccination in HTLV-1 carriers, a multicenter, prospe...
